The EU Commission invites parties to submit comments regarding a pharma company and its excessive pricing (Aspen)

Caracciolo, Eugenia

Previous article The Icelandic Competition Authority fines a telecoms company for commitment violations in the sale of English football on its linear pay-TV service (Síminn) Next article The EU Commission invites comments on a pharmaceutical company’s proposed commitment to reduce the price by 73% for six off-patent cancer medicines to remove the Commission’s excessive pricing concerns (Aspen)

14 Jul 2020

The EU Commission invites parties to submit comments regarding a pharma company and its excessive pricing (Aspen)

KEYWORDS

Reference

EU Commission, Aspen, Press Release, 14 July 2020

On 14 July 2020, the Commission invited interested parties to submit comments on the commitments offered by global pharma company Aspen to address competition concerns in relation to Aspen’s excessive pricing for six critical off-patent cancer medicines in several

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Eugenia Caracciolo
Van Bael & Bellis (Brussels)

Belgium 4 contributions 599 visits

Quotation

Eugenia Caracciolo, The EU Commission invites parties to submit comments regarding a pharma company and its excessive pricing (Aspen), 14 July 2020, e-Competitions Remedies for unilateral conduct, Art. N° 96290

Visites 146